Atara Biotherapeutics Inc
NASDAQ:ATRA

Watchlist Manager
Atara Biotherapeutics Inc Logo
Atara Biotherapeutics Inc
NASDAQ:ATRA
Watchlist
Price: 8.82 USD 1.26% Market Closed
Market Cap: 59m USD

Relative Value

The Relative Value of one ATRA stock under the Base Case scenario is 19.66 USD. Compared to the current market price of 8.82 USD, Atara Biotherapeutics Inc is Undervalued by 55%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ATRA Relative Value
Base Case
19.66 USD
Undervaluation 55%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
76
vs Industry
92
Median 3Y
8.4
Median 5Y
8.6
Industry
7.2
Forward
1.6
vs History
vs Industry
Median 3Y
-1
Median 5Y
-3
Industry
23.2
Forward
-1.6
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-2.6
Industry
19.3
vs History
vs Industry
Median 3Y
-1
Median 5Y
-2.5
Industry
22.5
vs History
vs Industry
70
Median 3Y
-0.5
Median 5Y
5.2
Industry
2.7
vs History
71
vs Industry
80
Median 3Y
4.6
Median 5Y
4.9
Industry
7.5
Forward
2.4
vs History
17
vs Industry
79
Median 3Y
-4.2
Median 5Y
0
Industry
9.4
vs History
0
vs Industry
27
Median 3Y
-0.5
Median 5Y
-1.4
Industry
4.6
Forward
-4.5
vs History
0
vs Industry
25
Median 3Y
-0.5
Median 5Y
-1.3
Industry
4.5
Forward
-1.7
vs History
vs Industry
27
Median 3Y
-0.7
Median 5Y
-1.5
Industry
4.9
vs History
vs Industry
24
Median 3Y
-0.7
Median 5Y
-1.5
Industry
3.7
vs History
58
vs Industry
63
Median 3Y
1.4
Median 5Y
4.1
Industry
4.9

Multiples Across Competitors

ATRA Competitors Multiples
Atara Biotherapeutics Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Atara Biotherapeutics Inc
NASDAQ:ATRA
56.3m USD 0.3 -3.8 13.1 94.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 361 436.7 -163 314.8 -198 316.3 -196 053.2
US
Abbvie Inc
NYSE:ABBV
337.1B USD 5.9 81.1 15.4 22.8
US
Amgen Inc
NASDAQ:AMGN
158.6B USD 4.7 26.8 14.4 23.7
US
Gilead Sciences Inc
NASDAQ:GILD
137.5B USD 4.8 23.1 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.8B USD 10.4 -117.1 24.9 26.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 050.2 -523.2 -569.7 -554.5
AU
CSL Ltd
ASX:CSL
115.8B AUD 4.9 27.3 16.9 21.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
56.5B USD 4 12.6 11.2 12.5
US
Seagen Inc
F:SGT
39.3B EUR 19.7 -60.6 -65.3 -58.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.2B USD 17.1 -149 -667.3 -334.4
P/E Multiple
Earnings Growth PEG
US
Atara Biotherapeutics Inc
NASDAQ:ATRA
Average P/E: 34.2
Negative Multiple: -3.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -163 314.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.1
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.1
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -117.1 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -523.2 N/A N/A
AU
CSL Ltd
ASX:CSL
27.3
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.6
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -149 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Atara Biotherapeutics Inc
NASDAQ:ATRA
Average EV/EBITDA: 15.1
13.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -198 316.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.9
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -569.7 N/A N/A
AU
CSL Ltd
ASX:CSL
16.9
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.2
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -667.3 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Atara Biotherapeutics Inc
NASDAQ:ATRA
Average EV/EBIT: 30.6
94.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 053.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.7
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.1
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -554.5 N/A N/A
AU
CSL Ltd
ASX:CSL
21.1
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.5
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -334.4 N/A N/A